Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Patrick Campbell , Selim Krim , Hector Ventura Added: 3 years ago
Heart failure remains a significant burden to the US healthcare system and contributes greatly to the morbidity and mortality of the population. The impact of an ageing population, improved survival in coronary artery disease (CAD) and adverse life-style choices will ultimately result in an increased burden on an already taxed health care system. Heart failure affects over 5 million people with… View more
Author(s): Gianluigi Savarese , Lars H Lund Added: 3 years ago
Heart failure (HF) is a complex clinical syndrome characterised by the reduced ability of the heart to pump and/or fill with blood.1,2 From a physiological point of view, HF can be defined as an inadequate cardiac output to meet metabolic demands or adequate cardiac output secondary to compensatory neurohormonal activation (generally manifesting as increased left ventricular filling pressure).2… View more
Author(s): Conor P Kerley Added: 3 years ago
Heart failure (HF) is a major cause of hospitalisation, morbidity and mortality. Nutritional factors are major contributors to HF precursors, including hypertension, obesity, dyslipidaemia, insulin resistance/diabetes and systemic inflammation. Multiple landmark trials, including Dietary Approaches to Stop Hypertension (DASH)1 and Prevención con Dieta Mediterránea (PREDIMED),2 have documented the… View more
Author(s): Carine E Hamo , Michelle W Bloom Added: 3 years ago
Heart disease and cancer are the two leading causes of death, together accounting for almost 50 % of deaths in the US.1 Unfortunately, the tremendous success in improving cancer survival is often attenuated by downstream cardiovascular complications from cancer therapy. Acute cardiac toxicity may limit the ability to use life-saving cancer therapy and chronic toxicity limits overall survival. As… View more
Dr David Conen is a cardiologist, scientist and principal investigator at the Population Health Institute at McMaster University in Hamilton, Canada. Dr Conen is Principal Investigator of two major international trials studying the treatment and prevention of atrial fibrillation – the COP-AF and ASPIRE-AF Trials. View more
Author(s): Edoardo Bertero , Pietro Ameri , Christoph Maack Added: 3 years ago
Heart failure (HF) and cancer represent two major causes of morbidity and mortality in developed countries.1,2 The prevalence of these conditions is growing as the age of the population and the burden of shared risk factors, such as diabetes and obesity, are constantly increasing. In past decades, the field of cardio-oncology has predominantly focused on prevention and treatment of cardiovascular… View more
Author(s): Howard C Herrmann Added: 5 years ago
Prof Howard C. Hermann (University of Pennsylvania, US) discusses prosthesis-patient mismatch - Incidence, predictors and outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement. Filmed by Radcliffe Cardiology on site TCT 2018. View more